Portfolio Companies
The next generation of leaders in biotechnology, pharmaceuticals, medtech, and digital health.
Ochre Bio
RNA-based therapeutics for liver disease. Signed a $1.3B deal with Boehringer Ingelheim.
Eligo Bioscience
Precision genetic medicine platform using bacteriophage-based delivery to edit the microbiome.
OmicEra Diagnostics
Proteomics-based early cancer detection. Acquired by Exact Sciences for €20M.
GEDEA Biotech
Innovative biotech company developing novel therapeutic approaches.
deepeye
AI-powered ophthalmology diagnostics platform for early disease detection.
eDITY
Gene editing platform with novel delivery mechanisms for therapeutic applications.
Bitbrain
Neurotechnology company developing brain-computer interface solutions for healthcare.
PhagoMed
Phage-based therapeutics. Acquired by BioNTech in a landmark exit.
Join our portfolio
Apply to Gold Track and get the expert support to scale your life sciences company.
Apply Now